Search

Search Results

• 

  Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study

  Carlos A. Jiménez-Ruiz, Marcos Garcia Rueda, Manuel A. Martinez Muñiz, Jacobo Sellarés, Maria A. Jiménez-Fuentes, Lourdes Lázaro Asegurado, Esther Rodríguez Gonzalez, Concepción Rodriguez Garcia, Oriol Armengol, Emilia Abad, Teresa Peña, Adolfo Domenech del Rio, Juan A. Riesco Miranda

  2017-12-19

  Published: December 19, 2017

  1492

  PDF: 866

  Supplementary: 207

• A pilot study on the application of the current European guidelines for the management of acute coronary syndrome without elevation of ST segment (NSTEMI) in the Emergency Department setting in the Italian region Lazio

  Gabriele Valli, Francesca De Marco, Maria Teresa Spina, Valentina Valeriano, Antonello Rosa, Valentina Minerva, Enrico Mirante, Maria Pia Ruggieri, Francesco Rocco Pugliese

  2015-11-24

  Published: November 24, 2015

  1778

  PDF: 795

• Smoking characteristics and cessation in patients with thromboangiitis obliterans

  C.A. Jiménez-Ruiz, L.C. Dale, J. Astray Mochales, L. Velázquez Buendía, I. de Granda Orive, A. Guirao García

  2016-02-10

  Published: February 10, 2016

  758

  PDF: 628
• 

  Cardiac Prevention and Rehabilitation “3.0â€: From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)

  Roberto F.E. Pedretti, Francesco Fattirolli, Raffaele Griffo, Marco Ambrosetti, Elisabetta Angelino, Silvia Brazzo, Ugo Corrà, Nicolò Dasseni, Pompilio Faggiano, Giuseppe Favretto, Oreste Febo, Marina Ferrari, Francesco Giallauria, Cesare Greco, Manuela Iannucci, Maria Teresa La Rovere, Mario Mallardo, Antonio Mazza, Massimo Piepoli, Carmine Riccio, Simonetta Scalvini, Luigi Tavazzi, Pier Luigi Temporelli, Gian Francesco Mureddu

  2018-10-26

  Published: October 26, 2018

  2255

  PDF: 1094
• 

  Prognostic impact of digoxin use for rate control of atrial fibrillation in patients ≥75 years of age

  Maria Teresa La Rovere, Egidio Traversi

  2018-06-07

  Published: June 7, 2018

  2983

  PDF: 535

• Cardiac Rehabilitation of patients with left ventricular assist device as “destination therapyâ€

  Francesco Fattirolli, Massimo Bonacchi, Costanza Burgisser, Tommaso Cellai, Sara Francini, Serafina Valente, Guido Sani, Gian Franco Gensini

  2016-01-19

  Published: January 19, 2016

  1053

  PDF: 1201

• Smoking cessation treatment for COPD smokers: the role of counselling

  C.A. Jiménez-Ruiz, K.O. Fagerström

  2015-11-26

  Published: November 26, 2015

  2493

  PDF: 1252

• Smoking cessation treatment for COPD smokers: the role of pharmacological interventions

  C.A. Jiménez-Ruiz, K.O. Fagerström

  2015-11-26

  Published: November 26, 2015

  2357

  PDF: 1416
• 

  Treatment of heart failure in the elderly: Which drugs are essential and which should be avoided

  Giampaolo Scorcu, Annarita Pilleri

  2018-06-07

  Published: June 7, 2018

  3500

  PDF: 893
• 

  Rhythm-control vs rate-control in the elderly: When to do it and which drug to prefer?

  Giovanni Luca Botto, Carlo Piemontese, Giovanni Russo

  2018-06-07

  Published: June 7, 2018

  3471

  PDF: 688

• Into the cognitive constructs related to adherence to treatment in CHD outpatients: the importance of accepting the disease limitations

  Antonia Pierobon, Anna Giardini, Giuseppina Majani, Simona Callegari, Francesca Lenta, Maria Teresa La Rovere, Oreste Febo

  2016-01-19

  Published: January 19, 2016

  953

  PDF: 494

• Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment

  Bruno Balbi

  2015-08-19

  Published: August 19, 2015

  896

  PDF: 585

• Brittle asthma

  O. Toungoussova, M.P. Foschino Barbaro, L.M. Esposito, G.E. Carpagnano, F.G. Salerno, R.W. Dal Negro, A. Spanevello

  2016-02-03

  Published: February 3, 2016

  2881

  PDF: 1774

• Rehabilitation of COPD patients: which training modality

  E. Clini, S. Costi, M. Romagnoli, F. Florini

  2004-09-30

  Published: September 30, 2004

  962

  PDF: 568

• From risk charts to guidelines: tools for evaluation and management of cardiovascular risk

  Cristina Castello, Furio Colivicchi, Mariagrazia Sclavo, Massimo Uguccioni, Alberto Genovesi Ebert, Maurizio G. Abrignani, Pompilio Faggiano, Carmine Riccio

  2016-02-05

  Published: February 5, 2016

  631

  PDF: 420

• Rivaroxaban in non valvular atrial fibrillation: subgroups analysis

  Cesare Greco

  2015-08-19

  Published: August 19, 2015

  1223

  PDF: 883

• Significant gas-exchange improvements reported after roflumilast in two cases of severe COPD

  Bruno Sposato

  2015-08-19

  Published: August 19, 2015

  585

  PDF: 586

• Two cases of COPD benefitting from therapy with roflumilast

  Chiara Francesca Carraro

  2015-08-19

  Published: August 19, 2015

  757

  PDF: 634

• Endothelial progenitor cells and vascular health: effects of lifestyle’s modifications

  Francesca Cesari, Anna Maria Gori, Ilaria Romagnuolo, Rosanna Abbate

  2015-12-01

  Published: December 1, 2015

  1013

  PDF: 794

• Varenicline and evaluated outcomes in smoking cessation programmes

  P. Santus, L. Bassi, A. Airoldi, F. Giovannelli, D. Radovanovic

  2015-11-26

  Published: November 26, 2015

  982

  PDF: 573
• 

  Non-pharmacological interventions for tobacco cessation: A systematic review of existing practices and their effectiveness

  Shyam Kanhaiya Saroj, Tushti Bhardwaj

  2022-03-25

  Published: March 25, 2022

  2982

  PDF: 1036